Literature DB >> 1586704

Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma.

C Bastard1, H Tilly, B Lenormand, C Bigorgne, D Boulet, A Kunlin, M Monconduit, H Piguet.   

Abstract

We report a series of 20 non-Hodgkin's lymphomas (NHL) in which cytogenetic analysis showed a translocation involving band 3q27 and the site of one of the three Ig genes (14q32, 2p12, 22q11) in the neoplastic cells. These cases were found in a series of 319 patients with clonal chromosomal abnormalities studied over a 7-year period. Fourteen patients had diffuse lymphoma, mainly of large cell type and the remaining six were follicular lymphomas. All cases studied were of B-cell phenotype. A t(3;14)(q27;q32) was commonest, found in 15 patients (4.7%), with the two variant translocations, t(3;22)(q27;q11) and t(2;3)(p12;q27), being found in three and two patients, respectively. Additional chromosomal defects were present in most patients, but two patients had this type of translocation as the sole abnormality. These results indicate that translocations involving band 3q27 and Ig genes are not uncommon, and suggest that a novel oncogene, located at band 3q27, may be implicated in B-cell NHL.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1586704

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  13 in total

Review 1.  Molecular diagnostic approach to non-Hodgkin's lymphoma.

Authors:  D A Arber
Journal:  J Mol Diagn       Date:  2000-11       Impact factor: 5.568

2.  Cytogenetic alterations affecting BCL6 are predominantly found in follicular lymphomas grade 3B with a diffuse large B-cell component.

Authors:  Tiemo Katzenberger; German Ott; Thomas Klein; Jörg Kalla; Hans Konrad Müller-Hermelink; M Michaela Ott
Journal:  Am J Pathol       Date:  2004-08       Impact factor: 4.307

Review 3.  Genetic abnormalities in non-Hodgkin's lymphomas and chronic lymphocytic leukaemia.

Authors:  M Merup
Journal:  Med Oncol       Date:  1998-07       Impact factor: 3.064

Review 4.  Transformation of follicular lymphoma.

Authors:  Izidore S Lossos; Randy D Gascoyne
Journal:  Best Pract Res Clin Haematol       Date:  2011-05-06       Impact factor: 3.020

5.  BCL-6 protein expression in AIDS-related non-Hodgkin's lymphomas: inverse relationship with Epstein-Barr virus-encoded latent membrane protein-1 expression.

Authors:  A Carbone; G Gaidano; A Gloghini; C Pastore; G Saglio; U Tirelli; R Dalla-Favera; B Falini
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

6.  Influence of methotrexate exposure on outcome in patients treated with MBVP chemotherapy for primary central nervous system lymphoma.

Authors:  Hélène Blasco; Delphine Senecal; Amélie Le Gouge; Emmanuelle Pinard; Isabelle Benz-de Bretagne; Philippe Colombat; Jean-Sébastien Hulot; Etienne Chatelut; Chantal Le Guellec
Journal:  Br J Clin Pharmacol       Date:  2010-09       Impact factor: 4.335

7.  BAZF, a novel Bcl6 homolog, functions as a transcriptional repressor.

Authors:  S Okabe; T Fukuda; K Ishibashi; S Kojima; S Okada; M Hatano; M Ebara; H Saisho; T Tokuhisa
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

Review 8.  Cell kinetics and cell cycle regulation in lymphomas.

Authors:  L Leoncini; S Lazzi; C Bellan; P Tosi
Journal:  J Clin Pathol       Date:  2002-09       Impact factor: 3.411

9.  Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;q11) in B-cell lymphomas.

Authors:  B W Baron; G Nucifora; N McCabe; R Espinosa; M M Le Beau; T W McKeithan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-06-01       Impact factor: 11.205

10.  Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma.

Authors:  B H Ye; S Chaganti; C C Chang; H Niu; P Corradini; R S Chaganti; R Dalla-Favera
Journal:  EMBO J       Date:  1995-12-15       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.